Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pancreatitis × Etomidate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatitis 1 Pancreatic Neoplasms 1 Fractures, Bone 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangiocarcinoma 1

Interventions

Octreotide 1 Midazolam 1 Meperidine 1 Hydrocortisone 1 Etomidate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed

63 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡